MVA-BN (IMVAMUNE) immunization in persons who have undergone prior hematopoietic stem cell transplant (HSCT): a phase I, placebo-controlled study of the safety, reactogenicity and immunogenicity of MVA immunization.

Trial Profile

MVA-BN (IMVAMUNE) immunization in persons who have undergone prior hematopoietic stem cell transplant (HSCT): a phase I, placebo-controlled study of the safety, reactogenicity and immunogenicity of MVA immunization.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Aug 2013

At a glance

  • Drugs Smallpox vaccine (Primary)
  • Indications Smallpox
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Aug 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.
    • 03 May 2012 Planned End Date changed from 1 Feb 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.
    • 01 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top